Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles

Metabolomics

Volumn 6, Issue 1, 2010, Pages 78-95

  Sugimoto, Masahiro ^a   Wong, David T ^a,b   Hirayama, Akiyoshi ^a   Soga, Tomoyoshi ^a   Tomita, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Capillary electrophoresis mass spectrometry; Oral cancer; Pancreatic cancer; Salivary metabolome

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 77949297718     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-009-0178-y     Document Type: Article

References (86)

1. Ackerstaff, E., Glunde, K., & Bhujwalla, Z. M. (2003). Choline phospholipid metabolism: A target in cancer cells? Journal of Cellular Biochemistry, 90, 525-533.
2. Aharoni, A., Ric de Vos, C. H., Verhoeven, H. A., et al. (2002). Nontargeted metabolome analysis by use of Fourier transform ion cyclotron mass spectrometry. OMICS, 6, 217-234.
3. Ayers, M., Symmans, W. F., Stec, J., et al. (2004). Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. Journal of Clinical Oncology, 22, 2284-2293.
4. Baran, R., Kochi, H., Saito, N., et al. (2006). MathDAMP: A package for differential analysis of metabolite profiles. BMC Bioinformatics, 7, 530.
5. Bolan, P. J., Meisamy, S., Baker, E. H., et al. (2003). In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magnetic Resonance in Medicine, 50, 1134-1143.
6. Brennan, M. F., Kattan, M. W., Klimstra, D., & Conlon, K. (2004). Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Annals of Surgery, 240, 293-298.
7. Brown, M., Dunn, W. B., Dobson, P., et al. (2009). Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. Analyst, 134, 1322-1332.
8. Byun, J. A., Lee, S. H., Jung, B. H., et al. (2008). Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry. Biomedical Chromatography, 22, 73-80.
9. Carlin, J. M., Ozaki, Y., Byrne, G. I., Brown, R. R., & Borden, E. C. (1989). Interferons and indoleamine 2, 3-dioxygenase: role in antimicrobial and antitumor effects. Experientia, 45, 535-541.
10. Casero, R. A, Jr., & Marton, L. J. (2007). Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nature Reviews. Drug Discovery, 6, 373-390.
11. Cooke, M., Leeves, N., & White, C. (2003). Time profile of putrescine, cadaverine, indole and skatole in human saliva. Archives of Oral Biology, 48, 323-327.
12. Dawes, C. (1972). Circadian rhythms in human salivary flow rate and composition. Journal of Physiology, 220, 529-545.
13. de Almeida Pdel, V., Gregio, A. M., Machado, M. A., de Lima, A. A., & Azevedo, L. R. (2008). Saliva composition and functions: A comprehensive review. Journal of Contemporary Dental Practice, 9, 72-80.
14. Dimery, I. W., Nishioka, K., Grossie, V. B, Jr., et al. (1987). Polyamine metabolism in carcinoma of the oral cavity compared with adjacent and normal oral mucosa. American Journal of Surgery, 154, 429-433.
15. Emekli-Alturfan, E., Demir, G., Kasikci, E., et al. (2008). Altered biochemical parameters in the saliva of patients with breast cancer. Tohoku Journal of Experimental Medicine, 214, 89-96.
16. Epstein, J. B., Zhang, L., & Rosin, M. (2002). Advances in the diagnosis of oral premalignant and malignant lesions. Journal Canadian Dental Association, 68, 617-621.
17. Fabian, T. K., Fejerdy, P., & Csermely, P. (2008). Salivary Genomics, transcriptomics and proteomics: The emerging concept of the oral ecosystem and their use in the early diagnosis of cancer and other diseases. Current Genomics, 9, 11-21.
18. Fang, F., He, X., Deng, H., et al. (2007). Discrimination of metabolic profiles of pancreatic cancer from chronic pancreatitis by high-resolution magic angle spinning 1H nuclear magnetic resonance and principal components analysis. Cancer Science, 98, 1678-1682.
19. Fiehn, O., Kopka, J., Dormann, P., et al. (2000). Metabolite profiling for plant functional genomics. Nature Biotechnology, 18, 1157-1161.
20. Fliser, D., Wittke, S., & Mischak, H. (2005). Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes. Electrophoresis, 26, 2708-2716.
21. Gao, K., Zhou, H., Zhang, L., et al. (2009). Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer. PLoS ONE, 4, e5875.
22. Gerner, E. W., & Meyskens, F. L, Jr. (2004). Polyamines and cancer: Old molecules, new understanding. Nature Reviews Cancer, 4, 781-792.
23. Goto, S., Okuno, Y., Hattori, M., Nishioka, T., & Kanehisa, M. (2002). LIGAND: Database of chemical compounds and reactions in biological pathways. Nucleic Acids Research, 30, 402-404.
24. Gross, N. D., Patel, S. G., Carvalho, A. L., et al. (2008). Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma. Head and Neck, 30, 1352-1360.
25. Haddadin, I. S., McIntosh, A., Meisamy, S., et al. (2009). Metabolite quantification and high-field MRS in breast cancer. NMR in Biomedicine, 22, 65-76.
26. Harrison, T., Bigler, L., Tucci, M., et al. (1998). Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: An exploratory study. Special Care in Dentistry, 18, 109-112.
27. Hedman, J., Sjoman, R., Sjostrom, I., & Twetman, S. (2006). Fluoride concentration in saliva after consumption of a dinner meal prepared with fluoridated salt. Caries Research, 40, 158-162.
28. Hirayama, A., Kami, K., Sugimoto, M., et al. (2009). Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Research, 69, 4918-4925.
29. Holmes, E., Loo, R. L., Stamler, J., et al. (2008). Human metabolic phenotype diversity and its association with diet and blood pressure. Nature, 453, 396-400.
30. Hu, S., Arellano, M., Boontheung, P., et al. (2008). Salivary proteomics for oral cancer biomarker discovery. Clinical Cancer Research, 14, 6246-6252.
31. Hu, S., Yu, T., Xie, Y., et al. (2007). Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics and Proteomics, 4, 55-64.
32. Ishikawa, Y., & Ishida, H. (2000). Aquaporin water channel in salivary glands. Japanese Journal of Pharmacology, 83, 95-101.
33. Jani, M., Tordai, H., Trexler, M., Banyai, L., & Patthy, L. (2005). Hydroxamate-based peptide inhibitors of matrix metalloprotease 2. Biochimie, 87, 385-392.
34. Jonsson, P., Johansson, A. I., Gullberg, J., et al. (2005). High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Analytical Chemistry, 77, 5635-5642.
35. Katz, A., Smith, B. L., Golshan, M., et al. (2008). Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. Journal of Clinical Oncology, 26, 2093-2098.
36. Katz-Brull, R., Margalit, R., & Degani, H. (2001). Differential routing of choline in implanted breast cancer and normal organs. Magnetic Resonance in Medicine, 46, 31-38.
37. Katz-Brull, R., Seger, D., Rivenson-Segal, D., Rushkin, E., & Degani, H. (2002). Metabolic markers of breast cancer: Enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Research, 62, 1966-1970.
38. Khuhawar, M. Y., Memon, A. A., Jaipal, P. D., & Bhanger, M. I. (1999). Capillary gas chromatographic determination of putrescine and cadaverine in serum of cancer patients using trifluoroacetylacetone as derivatizing reagent. Journal of Chromatography. B, Biomedical Science and Applications, 723, 17-24.
39. Kind, T., & Fiehn, O. (2006). Metabolomic database annotations via query of elemental compositions: Mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics, 7, 234.
40. Kind, T., & Fiehn, O. (2007). Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry. BMC Bioinformatics, 8, 105.
41. Kojima, K., Asmellash, S., Klug, C. A., et al. (2008). Applying proteomic-based biomarker tools for the accurate diagnosis of pancreatic cancer. Journal of Gastrointestinal Surgery, 12, 1683-1690.
42. Kolch, W., Neususs, C., Pelzing, M., & Mischak, H. (2005). Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrometry Reviews, 24, 959-977.
43. Li, Y., Elashoff, D., Oh, M., et al. (2006). Serum circulating human mRNA profiling and its utility for oral cancer detection. Journal of Clinical Oncology, 24, 1754-1760.
44. Li, Y., St. John, M. A., Zhou, X., et al. (2004). Salivary transcriptome diagnostics for oral cancer detection. Clinical Cancer Research, 10, 8442-8450.
45. Lloyd, D. K. (2008). Capillary electrophoresis analysis of biofluids with a focus on less commonly analyzed matrices. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 866, 154-166.
46. Mahadevan, S., Shah, S. L., Marrie, T. J., & Slupsky, C. M. (2008). Analysis of metabolomic data using support vector machines. Analytical Chemistry, 80, 7562-7570.
47. Maheshwari, S. R., Mukherji, S. K., Neelon, B., et al. (2000). The choline/creatine ratio in five benign neoplasms: Comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. AJNR American Journal of Neuroradiology, 21, 1930-1935.
48. Mann, G. E., & Yudilevich, D. L. (1987). Regulation of amino acid influx and efflux at the basolateral plasma membrane of the salivary gland epithelium: Effects of parasympathetic nerve stimulation. Journal of Dental Research, 66, 569-575.
49. Mao, L., Hong, W. K., & Papadimitrakopoulou, V. A. (2004). Focus on head and neck cancer. Cancer Cell, 5, 311-316.
50. Melvin, J. E. (1999). Chloride channels and salivary gland function. Critical Reviews in Oral Biology and Medicine, 10, 199-209.
51. Metzger, J., Luppa, P. B., Good, D. M., & Mischak, H. (2009). Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm. Critical Reviews in Clinical Laboratory Sciences, 46, 129-152.
52. Meurman, J. H., & Uittamo, J. (2008). Oral micro-organisms in the etiology of cancer. Acta Odontologica Scandinavica, 66, 321-326.
53. Michell, A. W., Mosedale, D., Grainger, D. J., & Barker, R. A. (2008). Metabolomic analysis of urine and serum in Parkinson's disease. Metabolomics, 4, 191-201.
54. Minami, Y., Kasukawa, T., Kakazu, Y., et al. (2009). Measurement of internal body time by blood metabolomics. Proceedings of the National Academy of Sciences of the United States of America, 106, 9890-9895.
55. Okamura, M., Kobayashi, M., Suzuki, F., Shimada, J., & Sakagami, H. (2007). Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line. Anticancer Research, 27, 3331-3337.
56. Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74-108.
57. Pickering, V., Jordan, R. C., & Schmidt, B. L. (2007). Elevated salivary endothelin levels in oral cancer patients-A pilot study. Oral Oncology, 43, 37-41.
58. Plumb, R., Granger, J., Stumpf, C., et al. (2003). Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LC-TOFMS): detection of strain, diurnal and gender differences. Analyst, 128, 819-823.
59. Reijenga, J. C., Martens, J. H., Giuliani, A., & Chiari, M. (2002). Pherogram normalization in capillary electrophoresis and micellar electrokinetic chromatography analyses in cases of sample matrix-induced migration time shifts. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 770, 45-51.
60. Reo, N. V. (2002). NMR-based metabolomics. Drug and Chemical Toxicology, 25, 375-382.
61. Saeed, A. I., Sharov, V., White, J., et al. (2003). TM4: A free, open-source system for microarray data management and analysis. Biotechniques, 34, 374-378.
62. Saito, N., Robert, M., Kochi, H., et al. (2009). Metabolite profiling reveals YihU as a novel hydroxybutyrate dehydrogenase for alternative succinic semialdehyde metabolism in Escherichia coli. Journal of Biological Chemistry, 284, 16442-16451.
63. Schiffer, E., Mischak, H., & Novak, J. (2006). High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics, 6, 5615-5627.
64. Schiffer, E., Mischak, H., Theodorescu, D., & Vlahou, A. (2008). Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform. World Journal of Urology, 26, 67-74.
65. Schnackenberg, L. K., Sun, J., Espandiari, P., et al. (2007). Metabonomics evaluations of age-related changes in the urinary compositions of male Sprague-Dawley rats and effects of data normalization methods on statistical and quantitative analysis. BMC Bioinformatics, 8(Suppl 7), S3.
66. Sidransky, D. (2002). Emerging molecular markers of cancer. Nature Reviews Cancer, 2, 210-219.
67. Silwood, C. J., Lynch, E., Claxson, A. W., & Grootveld, M. C. (2002). 1H and (13)C NMR spectroscopic analysis of human saliva. Journal of Dental Research, 81, 422-427.
68. Smith, C. A., Want, E. J., O'Maille, G., Abagyan, R., & Siuzdak, G. (2006). XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Analytical Chemistry, 78, 779-787.
69. Soga, T., Baran, R., Suematsu, M., et al. (2006). Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. Journal of Biological Chemistry, 281, 16768-16776.
70. Srivastava, A., Wang, J., Zhou, H., Melvin, J. E., & Wong, D. T. (2008). Age and gender related differences in human parotid gland gene expression. Archives of Oral Biology, 53, 1058-1070.
71. Streckfus, C. F., Bigler, L. R., & Zwick, M. (2006). The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: A feasibility study. Journal of Oral Pathology and Medicine, 35, 292-300.
72. Streckfus, C. F., Mayorga-Wark, O., Arreola, D., et al. (2008). Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast. Cancer Investigation, 26, 159-167.
73. Sugimoto, M., Kikuchi, S., Arita, M., et al. (2005). Large-scale prediction of cationic metabolite identity and migration time in capillary electrophoresis mass spectrometry using artificial neural networks. Analytical Chemistry, 77, 78-84.
74. Tabor, C. W., & Tabor, H. (1984). Polyamines. Annual Review of Biochemistry, 53, 749-790.
75. Takeda, I., Stretch, C., Barnaby, P., et al. (2009). Understanding the human salivary metabolome. NMR in Biomedicine, 22, 577-584.
76. Tiziani, S., Lopes, V., & Gunther, U. L. (2009) Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia. 11, 269-276, 264-269.
77. Vissers, Y. L., Dejong, C. H., Luiking, Y. C., et al. (2005). Plasma arginine concentrations are reduced in cancer patients: Evidence for arginine deficiency? American Journal of Clinical Nutrition, 81, 1142-1146.
78. Walenta, S., Wetterling, M., Lehrke, M., et al. (2000). High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Research, 60, 916-921.
79. Wallace, W. E., Kearsley, A. J., & Guttman, C. M. (2004). An operator-independent approach to mass spectral peak identification and integration. Analytical Chemistry, 76, 2446-2452.
80. Wishart, D. S., Tzur, D., Knox, C., et al. (2007). HMDB: The human metabolome database. Nucleic Acids Research, 35, D521-D526.
81. Witten, I. H., & Frank, E. (2005). Data mining: Practical machine learning tools and techniques. Boston, MA: Morgan Kaufman.
82. Woo, H. M., Kim, K. M., Choi, M. H., et al. (2009). Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clinica Chimica Acta, 400, 63-69.
83. Yang, C., Richardson, A. D., Smith, J. W., & Osterman, A. (2007). Comparative metabolomics of breast cancer. Pacific Symposium on Biocomputing, 12, 181-192.
84. Zhou, J., Xu, B., Huang, J., et al. (2009). 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma. Clinica Chimica Acta, 401, 8-13.
85. Zimmermann, B. G., & Wong, D. T. (2008). Salivary mRNA targets for cancer diagnostics. Oral Oncology, 44, 425-429.
86. Zurbig, P., & Mischak, H. (2008). Capillary electrophoresis coupled to mass spectrometry for biomarker discovery and diagnosis of kidney diseases. Contributions to Nephrology, 160, 107-126.